Bleeding risk in patients with multiple myeloma treated for venous thromboembolism: a MarketScan analysis.

Res Pract Thromb Haemost · 2023 · PMC9982328 · PMID 36873562

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

Our analysis also reveals a significant trend in the preferred anticoagulation agent for patients with MM.

also in 9,775 other papers

a notable trendno p-value reported

There was a notable trend over time in preferred anticoagulant prescribed, favoring DOACs over warfarin later in the study period.

also in 2,380 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.